BESTSELLER

Single-use Bioreactor Market - Growth, Trends, and Forecast (2020 - 2025)

The Market is Segmented on the basis of Type of Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), Molecule Type, End User, and Geography.

Market Snapshot

Study Period:

2016-2024

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global single-use bioreactor market is expected to witness a CAGR of 15.5% during the forecast period. Certain factors that are driving the market's growth include rapid adoption of single-use technologies (SUTs) by the industry, cost-effectiveness and lower downtime, and launch of new products.

The inclination of the industry toward using single‑use bioreactors is currently being influenced by the criticality of the step, the value of the product, and the time for product development and production. These single-use bioreactors are in high demand, from the medical sector. These reactors are thus adopted by the pharmaceutical, companies to manufacture drugs without any negotiations on their quality. One of the biggest advantages of the adoption of single‑use bioreactors is the flexibility. The increasing trend toward multi‑drug facilities demands the production of different drugs, using the same facility, in minimum time and with minimum costs.  

However, at some point, the capital investment is found to be exceeded by the repetitive cost for plasticware and single-use consumables. So, although fixed stainless steel equipment have high upfront costs in terms of installation and maintenance, the regular recurring expenses for single-use bioreactors (SUBs) is found to be higher. In addition, high costs may be involved in proper waste management of the vast amounts of disposables.

Scope of the Report

Single-use bioreactors, also known as disposable bioreactors, have now become an integral part of the biotechnology manufacturing facilities. Continuous product innovation and increasing R&D expenditure in manufacturing technology act as key drivers in improving the overall process and providing high-quality products. This facilitates the transition from stainless steel bioreactors to single-use bioreactors. Single-use bioreactors are comparatively safe, simple, and flexible. Thus, their usage is increasing.

Type of Product
Single-use Bioreactor Systems
Media Bags
Filtration Assemblies
Other Products
Cell Type
Mammalian Cell
Bacteria
Yeast
Other Cell Types
Molecule Type
Vaccines
Monoclonal Antibodies
Stem Cells
Recombinant Proteins
Other Molecule Types
End User
Pharmaceutical and Biopharmaceutical Industries
Contract Research Organizations (CRO)
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Single-use Bioreactor Systems are Expected to a Hold Significant Share in the Type of Product Segment

In the recent years, single-use bioreactors have been increasingly adopted in the modern biopharmaceutical processes. This is primarily owing to its unique ability to enhance flexibility, reduce investment, and limit operational costs. For industrial advantages, single-use bioreactors are the more attractive options for multiproduct facilities, with up to 6,000 liters. The applications of single-use bioreactors are wide, from academic to commercial-scale laboratories, in drug discovery, pharmaceutical, environmental, and life science, for the development of vaccines, antibodies, cell culture, biofuel manufacturing, and more. The recent years have witnessed companies specializing in the development of single-use bioreactor, which has modified the existing glass bioreactor to a single-use bioreactor, within seconds. Distek Inc. also developed a benchtop SUB system for mammalian cell growth and recombinant protein production.

To understand key trends, Download Sample Report

North America Dominates the Market and is Expected to do so during the Forecast Period

The pharmaceuticals and hi-tech product makers announced multimillion-dollar investments, to expand their manufacturing capabilities, which is a positive aspect for the market studied. For example, Abzena, a pharmaceutical company, began the installation of a new 500L BIOSTAT STR, single-use bioreactor, as part of a series of significant investments in its San Diego process development and manufacturing operations. Partnerships between industries and academic institutions have witnessed a significant rise, over the recent years. Such collaborations aim to leverage the R&D resources of various universities, in the region, along with the commercial therapeutics and vaccine development and manufacturing capabilities of the CMOs.

To understand geography trends, Download Sample Report.

Competitive Landscape

The global single-use bioreactor market is highly competitive and consists of a number of major players. Companies, like ABEC Inc, Celltainer, Distek Inc., Eppendorf AG, GE Healthcare, Merck KGaA, OmniBRx Biotechnologies, Pall Corporation, Sartorius AG, and Thermo Fisher Scientific, among others, hold substantial shares in the single-use bioreactor market.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rapid Adoption of Single-use Technologies (SUTs) by the Industry

      2. 4.2.2 Cost Effectiveness and Lower Downtime

      3. 4.2.3 Launch of New Products

    3. 4.3 Market Restraints

      1. 4.3.1 High Regular Recurring Expenses

      2. 4.3.2 Issues with Meeting the Standards of Good Manufacturing Practices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type of Product

      1. 5.1.1 Single-use Bioreactor Systems

      2. 5.1.2 Media Bags

      3. 5.1.3 Filtration Assemblies

      4. 5.1.4 Other Products

    2. 5.2 Cell Type

      1. 5.2.1 Mammalian Cell

      2. 5.2.2 Bacteria

      3. 5.2.3 Yeast

      4. 5.2.4 Other Cell Types

    3. 5.3 Molecule Type

      1. 5.3.1 Vaccines

      2. 5.3.2 Monoclonal Antibodies

      3. 5.3.3 Stem Cells

      4. 5.3.4 Recombinant Proteins

      5. 5.3.5 Other Molecule Types

    4. 5.4 End User

      1. 5.4.1 Pharmaceutical and Biopharmaceutical Industries

      2. 5.4.2 Contract Research Organizations (CRO)

      3. 5.4.3 Other End Users

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle East & Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle East & Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 ABEC Inc.

      2. 6.1.2 Celltainer

      3. 6.1.3 Distek Inc.

      4. 6.1.4 Eppendorf AG

      5. 6.1.5 GE Healthcare

      6. 6.1.6 Merck KGaA

      7. 6.1.7 OmniBRx Biotechnologies

      8. 6.1.8 Pall Corporation

      9. 6.1.9 Sartorius AG

      10. 6.1.10 Thermo Fisher Scientific

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject to Availability

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports